Abstract
Dilated (congestive) cardiomyopathy (DCM) is defined as a heart muscle disease of unknown etiology characterized by a severe impairment of systolic function, responstible for a progressive ventricular dilatation. In most cases, both ventricles are simultaneously involved but occasionnally a right ventricular pump failure precedes the left ventricular failure. Many associated or conditioning factors have been incriminated including prolonged alcohol abuse, malnutrition, pregnancy/puerperium, small coronary-vessel disease, viral infection, persistent inflammation with disorders of cellular immunity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies (1980) Br Heart J 44: 672
Goodwin JF (1982) The frontiers of cardiomyopathy. Br Heart J 48: 1
Goodwin JF (1970) Congestive and hypertrophic cardiomyopathies. A decade of study. Lancet i: 731
Abelmann WH (1984) Classification and natural history of primary myocardial disease. Prog Cardiovas Dis 27: 73
Leier CV, Unverferth DV (1983) Dobutamine. Ann Int Med 99: 490
Leier CV, Heban PT, Huss P et al (1978) Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58: 466
Loeb HS, Bredakis J, Gunnar RM (1977) Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 55: 375
Rossen RM, Aldermann EL, Harrison DC (1976) Circulatory response to vasodilator therapy in congestive cardiomyopathy. Br Heart J 38: 695
Cody RJ (1984) Angiotensin II-mediated vasoconstriction in chronic congestive heart failure and response to converting enzyme inhibition. Am J Med 77 Suppl 71
Goldberg LI (1978) Dopamine and dobutamine. Brit Med J 2: 1163
Sharma B, Goodwin JF (1978) Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle. Circulation 58: 450
Turini GA, Brunner HR, Grbic et al (1979) Improvement of chronic congestive hart failure by oral captopril. Lancet 1: 1213
Levine TB, Olivari MT, Cohn JN (1984) Hemodynamic and regional blood flow response to captogril in congestive heart failure. Am J Med 76: 38
Cleland JGF, Dargie HJ, Hodsman GP et al (1984) Captopril in heart failure. A double blind controlled trial. Br Heart J 52: 530
Cody RJ (1985) Clinical and hemodynamic experience with enalapril in congestive heart failure. Am J Cardiol 55: 36A
DiCarlo L, Chatterjee K, Parmley WW et al (1983) Enalapril: A new angiotensin-converting enzyme inhibitior in chronic heart failure: acute and chronic hemodynamic evaluations. J Am Coll Cardiol 2: 865
Sharpe DN, Murphy J, Coxon R, Hannan SF (1984) Enalapril in patients with chronic heart Failure: a placebo-controlled, randomized, double-blind study. Circulation 70: 271
Franciosa JA, Wilen MM, Jordan RA (1985) Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. J Am Coll Cardiol 5: 101
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Perret, C. (1986). Heart Failure in Dilated Cardiomyopathy. In: Vincent, J.L. (eds) 6th International Symposium on Intensive Care and Emergency Medicine. Update in Intensive Care and Emergency Medicine, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82801-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-82801-0_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16508-8
Online ISBN: 978-3-642-82801-0
eBook Packages: Springer Book Archive